ClinicalTrials.gov
public full text
Public Domain
Absolute Bioavailability of a Single Oral Dose of Selexipag in Healthy Subjects
The primary purpose of this phase 1 study is to investigate the absolute bio-availability of a single oral dose of selexipag, i.e., to assess the amount of selexipag which reaches the blood when administered as an oral tablet (ACT-293987) compared to an intravenous administration in healthy subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of Selexipag in Healthy Male Participant#848533
- Pharmacokinetic of Sevoflurane During a 48h Sedation in Intensive Care Unit With AnaConDa®#898071
- The Effectiveness of Sunnah on Sleeping on Sleep Quality, Fatigue, Depression and Anxiety Among Patient Undegroing Hemodialysis#839053
- Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1#981661
- A Study to Compare Two Bioanalytical Assays for Tebipenem#1102580
Record · ID 1047791
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive